Illustrative image – not actual.Cipla is planning to undertake a Rs.950 crore capacity expansion in three formulations facilities at Sikkim, Goa and Indore that will make the finished forms of medicine over the next two years.
Of the total investment, around Rs.180 crore will be invested in a tablet and injectible facility in Sikkim, Rs.400 crore will go towards the Goa plant that will make aerosols, capsules and tablets, while Indore will involve an investment of Rs.350 crore and will make form-filled sealed units.
Also See:
